These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8603268)

  • 1. HIV incidence among injection drug users.
    Longshore D; Anglin MD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):308-9. PubMed ID: 8603268
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV incidence among injection drug users enrolled in a Los Angeles methadone program.
    Kerndt PR; Weber M; Ford W; Prevots DR; Lehman JS
    JAMA; 1995 Jun; 273(23):1831-2. PubMed ID: 7776493
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV prevalence and incidence among injection drug users in Los Angeles.
    Longshore D; Anglin MD
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):738-9. PubMed ID: 8207655
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of HIV among injection drug users entering drug treatment programs in four US cities.
    Murrill CS; Prevots DR; Miller MS; Linley LA; Royalty JE; Gwinn M;
    J Urban Health; 2001 Mar; 78(1):152-61. PubMed ID: 11368194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV risk behaviors and HIV seropositivity among young injection drug users.
    Marrero Rodríguez CA; Robles RR; Colón HM; Freeman DH; Matos TD; Reyes JC
    P R Health Sci J; 1993 Apr; 12(1):7-12. PubMed ID: 8511250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6.
    López-Zetina J; Ford W; Weber M; Barna S; Woerhle T; Kerndt P; Monterroso E
    Sex Transm Infect; 2000 Dec; 76(6):462-9. PubMed ID: 11221130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexually transmitted diseases in a population of intravenous drug users: association with seropositivity to the human immunodeficiency virus (HIV).
    Nelson KE; Vlahov D; Cohn S; Odunmbaku M; Lindsay A; Antohony JC; Hook EW
    J Infect Dis; 1991 Sep; 164(3):457-63. PubMed ID: 1869836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell leukemia virus infection in non-intravenous drug using HIV seropositive men in Los Angeles.
    Aboulafia DM; Mitsuyasu RT; Slamon DJ
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):333-6. PubMed ID: 1676593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low estimates of HIV seroconversions among clients of a drug treatment clinic in San Francisco, 1995 to 1998.
    McFarland W; Kellogg TA; Louie B; Murrill C; Katz MH
    J Acquir Immune Defic Syndr; 2000 Apr; 23(5):426-9. PubMed ID: 10866236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV seroconversion among injection drug users in detention, Tehran, Iran.
    Jahani MR; Kheirandish P; Hosseini M; Shirzad H; Seyedalinaghi SA; Karami N; Valiollahi P; Mohraz M; McFarland W
    AIDS; 2009 Feb; 23(4):538-40. PubMed ID: 19182678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study.
    Johnson JG; Rabkin JG; Lipsitz JD; Williams JB; Remien RH
    Compr Psychiatry; 1999; 40(1):31-4. PubMed ID: 9924874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection, race, and drug-treatment history.
    Watters JK; Lewis DK
    AIDS; 1990 Jul; 4(7):697. PubMed ID: 2397066
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.
    Nelson KE; Galai N; Safaeian M; Strathdee SA; Celentano DD; Vlahov D
    Am J Epidemiol; 2002 Oct; 156(7):641-53. PubMed ID: 12244033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.
    Chitwood DD; Griffin DK; Comerford M; Page JB; Trapido EJ; Lai S; McCoy CB
    Am J Public Health; 1995 Nov; 85(11):1538-42. PubMed ID: 7485667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of HIV risk behaviors between new and long-term injection drug users.
    Chitwood DD; Comerford M; Kitner KR; Palacios W; Sanchez J
    Subst Use Misuse; 2001 Jan; 36(1-2):91-111. PubMed ID: 11305356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated candidiasis in two HIV-positive intravenous drug users.
    de Ruiter A; Lloyd M; Wood C; Graham E; Bingham JS
    Int J STD AIDS; 1995; 6(1):56-8. PubMed ID: 7727587
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD; Williams AB; Truong HT; Do NH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users.
    van der Werf MJ; van Benthem BH; van Ameijden EJ
    Addiction; 2000 Mar; 95(3):383-92. PubMed ID: 10795359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incarceration history as a risk factor for HIV infection among Puerto Rican injection drug users.
    Robles RR; Marrero CA; Freeman DH; Colón HM; Matos TD; Sahai H
    P R Health Sci J; 1993 Apr; 12(1):13-7. PubMed ID: 8511241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males.
    Rezza G; Lazzarin A; Angarano G; Zerboni R; Sinicco A; Salassa B; Pristerà R; Barbanera M; Ortona L; Aiuti F
    Eur J Epidemiol; 1990 Mar; 6(1):99-101. PubMed ID: 2188852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.